Print

Print


Researchers Identify Another Possible Parkinson's Gene
By Ed Edelson - HealthDay Reporter

WEDNESDAY, Nov. 3 (HealthDayNews) -- Israeli researchers have added
another gene to the list of those possibly linked to Parkinson's
disease, saying their finding could one day "affect the treatment
options available to patients."

The gene is one that, in a mutated form, causes Gaucher's disease, a
genetic condition in which lipids -- blood fats -- can't be
metabolized properly. There is a high incidence of the disease among
Ashkenazi Jews, who are from Eastern Europe.

Researchers at the Rambam Medical Center in Haifa said their study of
99 Ashkenazi Jews with Parkinson's disease found that 31 of them had
mutations of the glucocerebrosidase (GBA) gene, which produces a
protein that metabolizes fats.

That finding adds support to the theory that Parkinson's disease,
which affects one of every 100 people over age 60 and causes
progressive loss of muscle control, results from faulty lipid
metabolism that slowly kills nerve cells.

The research appears in the Nov. 4 issue of the New England Journal
of Medicine.

The finding "holds a lot of promise for therapy," said Dr. Mel B.
Feany, an associate professor of pathology at Brigham and Women's
Hospital in Boston, who wrote an accompanying editorial in the
journal.

"If we understand that abnormal lipids contribute to the death of
cells, there are a number of therapies that can alter the composition
of lipids," Feany said.

Her editorial lists nine other genes that have been implicated in
Parkinson's disease. What has emerged from the genetic work is a
"general model" of how genetic malfunctions work on the molecular
level to cause nerve cell death in people with Parkinson's, she said.

Failure to metabolize lipids properly causes proteins in nerve cells
to clump together abnormally in Parkinson's patients, the model says.
Previously identified mutations cause protein clumping within nerve
cells, while the one described by the Israeli researchers affects
proteins in cell membranes, Feany said.

While scientists aren't sure why Parkinson's disease develops, they
believe that genes are only part of the cause. Environmental factors
also are believed to cause the disease. For example, exposure to
pesticides is known to increase the risk for some people, while
smoking cigarettes and drinking coffee have been found to decrease
the risk. But, Feany said, "We don't want to tell people to smoke to
reduce their risk of Parkinson's."

Still research on the genetics of the disease is "so exciting," she
said. She is working with fruit flies, which are "simple organisms
but do have brains" and can be manipulated to have a form of
Parkinson's, Feany said.

"They will eat anything you give them," she said. "We are feeding
them a lot of drugs to see whether any of them can prevent the
condition."

It's definitely long-range work, with lots to be done before any
human trial can be envisioned, Feany said. Discovery of the ideal
drug that could prevent Parkinson's would raise another question: Who
should get the drug?

That depends on the characteristics of the drug, Feany said. "If it
is not toxic, it could have a wider range of use. If it has
toxicities, it would be restricted to patients who have no other
option open to them."

An ultimate goal is to stop the disease before it starts, she said:
"There are very important research efforts under way to identify
people who will develop Parkinson's before there are any symptoms."

Parkinson's disease is a slowly progressive neurodegenerative
disorder caused by damaged or dead nerve cells in the region of the
brain that controls balance and coordinates muscle movement.
Eventually, the brain is no longer able to direct or control muscle
movement in a normal manner.

People with Parkinson's disease may have trouble walking, talking or
completing simple tasks that depend on coordinated muscle movements,
according to U.S. health officials.

More information

To learn more about Parkinson's disease, visit

The National Institute of Neurological Diseases and Stroke
http://www.ninds.nih.gov/health_and_medical/disorders/parkinsons_disea
se.htm

SOURCE: Forbes, NY
http://tinyurl.com/4c6v5

* * *Murray Charters <[log in to unmask]>
Please place this address in your address book
Please purge all others

Web site: Parkinsons Resources on the WWWeb
http://www.geocities.com/murraycharters

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn